Page 5 - Lifebit Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lifebit biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lifebit Biotech Today - Breaking & Trending Today

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

Search jobs
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
Breakthrough results in the treatment of a type of heart failure, which is extremely difficult to manage
Strong progress in mental health pipeline
Good business performance in all areas, despite ongoing impact of COVID-19
Ingelheim, August 3, 2021 – In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. The company’s success is based on its rich R&D portfolio with a focus on diseases with high unmet medical need. The R&D pipeline in Human Pharma comprises more than 60 new substances and around 100 clinical and pre-clinical projects. This pipeline has the potential to deliver up to 15 medicines for approval by 2025. ....

Rheinland Pfalz , Michael Schmelmer , Eli Lilly , Quantum Technology , Application Consortium , European Commission , Boehringer Ingelheim , Drug Administration , Group Functions , Animal Health , Human Pharma , Breakthrough Therapy Designation , Cognitive Impairment Associated , Biopharmaceutical Contract Manufacturing , Managing Directors , Lifebit Biotech , Contract Manufacturing , ரைன்லேண்ட் ப்ஃப்யால்ஸ் , எலி லில்லி , குவாண்டம் தொழில்நுட்பம் , ஐரோப்பிய தரகு , போஹெரிங்கர் இஂகல்‌ஹைம் , குழு செயல்பாடுகள் , விலங்கு ஆரோக்கியம் , மனிதன் பார்மா , திருப்புமுனை சிகிச்சை பதவி ,

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Rheinland Pfalz , Matthias Knotzer , Michael Schmelmer , Eli Lilly , Quantum Technology , Application Consortium , European Commission , Boehringer Ingelheim , Drug Administration , Group Functions , Corporate Communications , Animal Health , Human Pharma , Breakthrough Therapy Designation , Cognitive Impairment Associated , Biopharmaceutical Contract Manufacturing , Managing Directors , Lifebit Biotech , Contract Manufacturing , Business Wire , ரைன்லேண்ட் ப்ஃப்யால்ஸ் , எலி லில்லி , குவாண்டம் தொழில்நுட்பம் , ஐரோப்பிய தரகு , போஹெரிங்கர் இஂகல்‌ஹைம் , குழு செயல்பாடுகள் ,

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Eric Haaksma , Maria Chatzou Dunford , Boehringer Ingelheim , Lifebit Biotech , போஹெரிங்கர் இஂகல்‌ஹைம் ,

Boehringer Ingelheim to detect animal diseases using AI

Boehringer Ingelheim to detect animal diseases using AI
9 June 2021 |
The captured insights can accelerate detection of the latest animal disease outbreaks
Animal health firm Boehringer Ingelheim will partner with Lifebit Biotech to utilise artificial intelligence for the detection of global disease outbreaks.
Technology firm Lifebit’s REAL platform automatically detects and tracks animal disease outbreaks using real-world evidence and AI.
The captured insights can accelerate detection of the latest outbreaks including transboundary diseases and emerging pathogens.
Now researchers from the two organisations will work to combine real-world evidence and the latest AI algorithms to identify infectious disease outbreaks and respond accordingly. ....

Eric Haaksma , Maria Chatzou Dunford , Boehringer Ingelheim , Lifebit Biotech , போஹெரிங்கர் இஂகல்‌ஹைம் ,